Listed

Outset Medical, Inc.: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 6, 2021 and accepted by EDGAR at May 5, 2021, 18:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$22.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$22.6mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-01-01 to 2021-03-31$289.0kus-gaap:GrossProfit
Research and development3 months2021-01-01 to 2021-03-31$7.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-01-01 to 2021-03-31−$29.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$422.0kus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31$39.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31−$30.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31−$0.70us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31−$0.70us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-3142,760,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31−$38.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$919.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$251.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$321.7mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$379.8mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$34.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$73.2mus-gaap:Liabilities
Long-term debtAt period end2021-03-31$29.7mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2021-03-31$306.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-21-024269. Last ingested by Listed: Nov 14, 2026, 11:29 ET. Listed shows no prices and gives no investment advice.